What is JD Health International Revenue per Share?
JD Health International's revenue per share for the
six
months ended in Dec. 2023 was HK$9.13.
JD Health International's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$18.51.
Warning Sign:
JD Health International Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of JD Health International was 11.50% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 21.20% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 47.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for JD Health International's Revenue per Share or its related term are showing as below:
HKSE:06618'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 21.2 Med: 61.25 Max: 70.4
Current: 21.2
During the past 7 years, JD Health International's highest 3-Year average Revenue Per Share Growth Rate was 70.40% per year. The lowest was 21.20% per year. And the median was 61.25% per year.
HKSE:06618's 3-Year Revenue Growth Rate is ranked better than 76.52% of 575
companies
in the Healthcare Providers & Services industry
Industry Median: 9.6
vs HKSE:06618: 21.20
JD Health International Revenue per Share Historical Data
The historical data trend for JD Health International's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of JD Health International's Revenue per Share
For the Medical Care Facilities subindustry, JD Health International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International's PS Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's PS Ratio distribution charts can be found below:
* The bar in red indicates where JD Health International's PS Ratio falls into.
JD Health International Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
JD Health International's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$18.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International (HKSE:06618) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
JD Health International Revenue per Share Related Terms
Thank you for viewing the detailed overview of JD Health International's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
JD Health International (HKSE:06618) Business Description
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06618 has been successfully added to your 